Microba Life Sciences Limited
ASX:MAP.AX
0.17 (AUD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8.817 | 3.273 | 1.636 | 3.269 | 1.634 | 2.151 | 1.076 | 2.49 | 1.245 | 2.199 | 1.099 | 2.04 | 1.02 | 1.693 | 0.846 |
| Cost of Revenue
| 12.993 | 7.679 | 0.935 | 6.596 | 0.813 | 5.597 | 0.558 | 6.822 | 0.648 | 5.617 | 0.513 | 5.045 | 0.449 | 3.992 | 0.399 |
| Gross Profit
| -4.176 | -4.407 | 0.701 | -3.327 | 0.822 | -3.446 | 0.518 | -4.332 | 0.596 | -3.418 | 0.586 | -3.005 | 0.571 | -2.299 | 0.448 |
| Gross Profit Ratio
| -0.474 | -1.346 | 0.428 | -1.018 | 0.503 | -1.602 | 0.481 | -1.74 | 0.479 | -1.555 | 0.533 | -1.474 | 0.56 | -1.358 | 0.529 |
| Reseach & Development Expenses
| 3.642 | 7.194 | 3.706 | 5.797 | 2.898 | 3.54 | 1.77 | 2.788 | 1.283 | 2.596 | 1.409 | 1.082 | 0.819 | 0.457 | 0.229 |
| General & Administrative Expenses
| 0 | 0.394 | 0.394 | 0.308 | 0.308 | 0.259 | 0.259 | 0.295 | 0.295 | 0.284 | 0.284 | 0.119 | 0.119 | 0.292 | 0.292 |
| Selling & Marketing Expenses
| 0 | 0.229 | 0.229 | 0.162 | 0.162 | 0.185 | 0.185 | 0.145 | 0.145 | 0.126 | 0.126 | 0.073 | 0.073 | 0.096 | 0.096 |
| SG&A
| 3.719 | 3.705 | 3.185 | 2.133 | 2.387 | 1.987 | 2.431 | 1.514 | 2.767 | 1.625 | 2.369 | 1.336 | 1.976 | 1.391 | 1.679 |
| Other Expenses
| 0.046 | 0.005 | 0 | 0 | 0 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 7.315 | 10.894 | 6.693 | 7.929 | 4.67 | 5.525 | 3.415 | 4.301 | 3.307 | 4.221 | 3.604 | 2.418 | 3.263 | 1.848 | 1.557 |
| Operating Income
| -11.49 | -15.301 | -7.15 | -11.257 | -5.628 | -8.971 | -4.487 | -8.633 | -4.321 | -7.639 | -3.815 | -5.423 | -2.687 | -4.147 | -2.074 |
| Operating Income Ratio
| -1.303 | -4.675 | -4.369 | -3.444 | -3.444 | -4.169 | -4.171 | -3.467 | -3.471 | -3.474 | -3.47 | -2.659 | -2.635 | -2.45 | -2.45 |
| Total Other Income Expenses Net
| 3.012 | 3.79 | 1.395 | 4.261 | 2.131 | 3.291 | 1.647 | 3.202 | 1.606 | 1.609 | 0.8 | 0.083 | 0.017 | 1.964 | 0.982 |
| Income Before Tax
| -8.479 | -11.511 | -5.756 | -6.995 | -3.498 | -5.679 | -2.84 | -5.431 | -2.715 | -6.03 | -3.015 | -5.34 | -2.67 | -2.183 | -1.092 |
| Income Before Tax Ratio
| -0.962 | -3.517 | -3.517 | -2.14 | -2.14 | -2.64 | -2.64 | -2.181 | -2.181 | -2.743 | -2.743 | -2.618 | -2.618 | -1.29 | -1.29 |
| Income Tax Expense
| -0.028 | -0.023 | 0.012 | 0.006 | 0.003 | -0 | 0 | 0.009 | 0.005 | 0 | 0 | -0 | 0 | 0 | 0 |
| Net Income
| -8.45 | -11.488 | -5.744 | -7.001 | -3.501 | -5.679 | -2.84 | -5.44 | -2.72 | -6.03 | -3.015 | -5.34 | -2.67 | -2.183 | -1.092 |
| Net Income Ratio
| -0.958 | -3.51 | -3.51 | -2.142 | -2.142 | -2.64 | -2.64 | -2.185 | -2.185 | -2.743 | -2.743 | -2.618 | -2.618 | -1.29 | -1.29 |
| EPS
| -0.019 | -0.031 | -0.016 | -0.019 | -0.01 | -0.019 | -0.01 | -0.019 | -0.01 | -0.021 | -0.019 | -0.018 | -0.013 | -0.008 | 0 |
| EPS Diluted
| -0.019 | -0.031 | -0.015 | -0.019 | -0.01 | -0.019 | -0.01 | -0.019 | -0.01 | -0.021 | -0.019 | -0.018 | -0.013 | -0.008 | 0 |
| EBITDA
| -9.664 | -14.257 | -6.823 | -10.363 | -5.561 | -8.222 | -4.113 | -7.775 | -4.306 | -6.954 | -3.472 | -4.822 | -2.489 | -3.53 | -1.765 |
| EBITDA Ratio
| -1.096 | -4.356 | -4.169 | -3.17 | -3.402 | -3.822 | -3.823 | -3.123 | -3.459 | -3.163 | -3.158 | -2.364 | -2.441 | -2.085 | -2.085 |